KD Pharma’s professional expertise, state-of-the-art assets and proven track record in regulatory compliance with the FDA allow us to become your preferred CDMO solutions partner.
One partner along the whole product value-chain and lifecycle
KD Pharma partners with its customers for integration of development from early development to late product lifecycle management. Our Industrialization experience, injected early in the process development phase, has proven to increase speed to market and provide proper upsteam raw materials selection. With our complete range of facilities, from kg to multi-ton scale, we are supporting the full value-chain saving time and creating opportunites.
Technology-Driven CDMO
KD Pharma has the broadest technology base for our markets. The combination of purification and chemical synthesis technologies, including chromatography, distillation, high pressure reactions and cryogenic chemistry, is unique for a European CDMO.
Customer centric
KD Pharma´s flat organizational structure with direct communication lines results in fast and seamless decision making, benefitting customer´s projects. With a customer centric approach we are listening to our customer’s needs with dedicated project management. With the mindset that our team is the extension of our customer‘s ressources.
Supply Agility and Flexibility
Markets are very dynamic and KD Pharma is the right partner to support the required agility in inventory and supply management. With our transparency risks can be manage from upstream sourcing strategy to safety stock models. Our assets are also able to integrate numerous chemistries, reducing need for multi-sourcing.
Reliable – Quality oriented
The PDCA (Plan -Do- Check Act) is part of our DNA in order to design, develop and deliver safe and effective products to patients and consumers, as a fundamental element of our Company’s Purpose and Mission.
